IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 46 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $184,500 | -59.8% | 200,000 | -60.0% | 0.00% | – |
Q4 2022 | $458,750 | -0.1% | 500,000 | 0.0% | 0.00% | – |
Q3 2022 | $459,000 | +4.3% | 500,000 | 0.0% | 0.00% | – |
Q2 2022 | $440,000 | -2.9% | 500,000 | 0.0% | 0.00% | – |
Q1 2022 | $453,000 | 0.0% | 500,000 | 0.0% | 0.00% | – |
Q4 2021 | $453,000 | -0.7% | 500,000 | 0.0% | 0.00% | – |
Q3 2021 | $456,000 | – | 500,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 42,313,000 | $39,204,306 | 3.17% |
DeepCurrents Investment Group LLC | 76,898,000 | $70,957,707 | 2.76% |
Penn Mutual Asset Management | 2,756,000 | $2,537,097 | 2.41% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 129,852,000 | $120,146,001 | 2.39% |
Sonora Investment Management Group, LLC | 18,930,000 | $17,542,962 | 1.53% |
DLD Asset Management, LP | 15,000,000 | $13,968,750 | 1.18% |
BRAIDWELL LP | 36,533,000 | $33,800,477 | 1.12% |
Worth Venture Partners, LLC | 1,455,000 | $1,349,149 | 0.66% |
Verition Fund Management LLC | 22,266 | $20,600,592 | 0.28% |
III Capital Management | 5,100,000 | $4,712,060 | 0.26% |